SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-025554
Filing Date
2021-05-07
Accepted
2021-05-07 16:07:40
Documents
75
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q flgt-10q_20210331.htm 10-Q 2014630
2 EX-10.1 flgt-ex101_24.htm EX-10.1 35695
3 EX-31.1 flgt-ex311_8.htm EX-31.1 20829
4 EX-31.2 flgt-ex312_7.htm EX-31.2 20856
5 EX-32.1 flgt-ex321_6.htm EX-32.1 18210
  Complete submission text file 0001564590-21-025554.txt   7720124

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT flgt-20210331.xml EX-101.INS 1709565
7 XBRL TAXONOMY EXTENSION SCHEMA flgt-20210331.xsd EX-101.SCH 60576
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE flgt-20210331_cal.xml EX-101.CAL 65239
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flgt-20210331_def.xml EX-101.DEF 169070
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE flgt-20210331_lab.xml EX-101.LAB 443581
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flgt-20210331_pre.xml EX-101.PRE 332461
Mailing Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780
Business Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

IRS No.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37894 | Film No.: 21902672
SIC: 8071 Services-Medical Laboratories